Ocuphire Pharma Inc. (OCUP)
NASDAQ: OCUP
· Real-Time Price · USD
1.17
-0.16 (-12.03%)
At close: Oct 23, 2024, 10:00 PM
Ocuphire Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -61.01M | -61.35M | -60.26M | -27.19M | -14.11M | -11.3M | -9.99M | 28.75M | 18.66M | 18.69M | 17.89M | -22.37M | -22.07M | -24.27M | -56.69M | -69.06M | -66.08M | -60.55M |
Depreciation & Amortization | 34K | 20K | 7K | 3K | 4K | 5K | 6K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K |
Stock-Based Compensation | 3.44M | 3.35M | 3.43M | 3.28M | 3.08M | 3.69M | 3.51M | 3.22M | 3.14M | 2.17M | 1.81M | 1.86M | 1.85M | 1.86M | 1.91M | 1.95M | 2.09M | 1.94M |
Other Working Capital | 3.03M | 2.72M | 3.99M | 3.26M | 949K | 2.39M | 1.5M | -1.7M | -1.89M | -3.26M | -3.74M | 55K | 609K | 1.02M | -200K | 139K | -117K | -766K |
Other Non-Cash Items | 31.49M | 36.96M | 40.56M | -5.39M | -5.85M | -7.72M | -9.56M | -822K | -768K | -7K | 50K | 162K | 181K | 1.48M | 35.22M | 48.17M | 48.73M | 47.81M |
Deferred Income Tax | -8.67M | -8.67M | -8.67M | 8.67M | 10.4M | 10.85M | 10.85M | 2.18M | 445K | n/a | n/a | n/a | n/a | n/a | n/a | -79K | -958K | -1.3M |
Change in Working Capital | -6.8M | -7.43M | -7.03M | 10.33M | -1.7M | 3.16M | 4.08M | -10.2M | -273K | -4.14M | -5.55M | 95K | 1.13M | 1.2M | 181K | 933K | 658K | 216K |
Operating Cash Flow | -41.51M | -38.53M | -35.25M | -13.59M | -11.46M | -3.18M | -1.11M | 23.13M | 21.64M | 16.84M | 14.31M | -20.12M | -19.21M | -19.73M | -19.37M | -18.08M | -15.55M | -11.88M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100K | -100K | -100K | -100K | -1.48M | -1.48M | -1.48M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 68K | 68K | 68K |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 1.21M | 1.21M | 1.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100K | -100K | -100K | -100K | 471K | 3.47M | 3.47M |
Investing Cash Flow | 1.21M | 1.21M | 1.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100K | -100K | -100K | -100K | 539K | 3.54M | 3.54M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 538K | 323K | 323K | 861K | 323K | 538K | 538K | 449K | 1.43M | 1.75M |
Common Stock Repurchased | 896K | 451K | n/a | -42K | -42K | -42K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 25.68M | 24.75M | 4.22M | -328K | -331K | -309K | -248K | -118K | -584K | -639K | -965K | -1.15M | -713K | -1.76M | -1.42M | -3.33M | -3.25M | -2.22M |
Financial Cash Flow | 18.39M | 19.02M | 936K | 7.87M | 12.89M | 11.36M | 8.98M | 5.36M | 1.32M | 2.9M | 3.79M | 11.83M | 12.1M | 28.48M | 27.61M | 39.07M | 38.4M | 20.68M |
Net Cash Flow | -13.76M | -10.15M | -24.96M | -5.72M | 1.43M | 8.17M | 7.87M | 28.5M | 22.95M | 19.74M | 18.1M | -8.39M | -7.21M | 8.65M | 8.13M | 21.53M | 23.38M | 9.34M |
Free Cash Flow | -41.51M | -38.53M | -35.25M | -13.59M | -11.46M | -3.18M | -1.11M | 23.13M | 21.64M | 16.84M | 14.31M | -20.22M | -19.31M | -19.83M | -19.47M | -19.56M | -17.03M | -13.35M |